Rapid Micro Biosystems Shares Rise After Samsung Biologics Partnership
By Dean Seal
Shares of Rapid Micro Biosystems rose after the company said its Growth Direct platform has been selected by Samsung Biologics for the automation of microbial quality control processes.
The stock was up 9% at 98 cents in recent trading. Shares were trading at around $1.38 a year ago.
The life-sciences technology company said before the bell on Thursday that Samsung Biologics picked the platform to help increase efficiency and deliver more robust data integrity as well as scalable quality control operations.
No further details about the arrangement were given.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 04, 2024 10:06 ET (15:06 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks